International nonproprietary name: difference between revisions
Diff·revision 7 → 8·06:15, 27 Dec 2024
Difference between revision 7 and revision 8 of International nonproprietary name. 5 lines changed; the page grew by 514 bytes.
| Revision 7 — 14:33, 13 Dec 2024 ExenatideEzra (talk) expand §Stems relevant here 2,241 bytes ±0 | Revision 8 — 06:15, 27 Dec 2024 ParentCatPansy (talk) add the peptide length to the infobox 2,755 bytes +514 | ||
|---|---|---|---|
| 27 | Stems are extended and refined as classes proliferate, so a newly assigned name may use a stem that did not exist a decade earlier.{{r|who_inn}} | 27 | Stems are extended and refined as classes proliferate, so a newly assigned name may use a stem that did not exist a decade earlier.{{r|who_inn}} |
| 28 | 28 | ||
| + | 29 | == Relationship to trade and chemical names == | |
| + | 30 | A substance has one INN, potentially several trade names, and a systematic chemical name that is unambiguous and unusable in conversation. The INN sits between them: unique, public, and short enough to speak.{{r|who_inn}} | |
| + | 31 | ||
| + | 32 | Trade names are trademarks, differ between jurisdictions, and are chosen for marketing rather than for information. A trade name conveys nothing about pharmacological class by design, since a trademark resembling an INN stem would be refused. | |
| + | 33 | ||
| 29 | == References == | 34 | == References == |
| 30 | {{reflist}} | 35 | {{reflist}} |